Skip to content

Exploring the Risk Factors of Otomycosis: A Case-Control Study

Exploring the Risk Factors of Otomycosis: A Case-Control Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06530069
Enrollment
200
Registered
2024-07-31
Start date
2024-08-01
Completion date
2024-08-15
Last updated
2024-08-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otomycosis

Keywords

Otomycosis, predisposing factor

Brief summary

The goal of this observational study is to explore the risk factors of fungal otitis externa in the fungal otitis externa patients The main question it aims to answer is: What behaviors lead to the occurrence of fungal otitis externa? Participants will complete a detailed questionnaire survey. If there is a comparison group: Researchers will compare the healthy group and the disease group to see if there are any differences.

Interventions

exposures: Ear cleaning, swimming, wearing earphones, diabetes, immunosuppression, antibiotic ear drops, narrowing of the external auditory canal, etc.

Sponsors

Zhongshan Hospital Xiamen University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Symptoms in the case group include tinnitus, ear fullness or blockage, itching, ear pain, discharge, and hearing loss. Physical examination reveals the presence of hyphae, scabs, secretions, masses, pus, red skin, erosion, swelling, or granulation in the ear canal. Laboratory fungal cultures must be positive. The control group does not have the aforementioned ear symptoms and has not sought medical attention for ear-related symptoms.

Exclusion criteria

* Patients with otitis media, tympanic membrane perforation, or post-radiotherapy.

Design outcomes

Primary

MeasureTime frameDescription
Odds Ratio1monthThe ratio of exposed to non-exposed individuals in the case group divided by the ratio of exposed to non-exposed individuals in the control group.

Countries

China

Contacts

Primary ContactChunsheng Ye
578881502@qq.com+8613400661815

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026